Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome.

Sindy BlauschmidtThomas GreitherKatharina LampeSolveig KöllerPetra KaltwaßerHermann M Behre

Published in: Clinical endocrinology (2017)

The results suggested that a deregulation of DPP4 serum levels could be an additional characteristic of the metabolic imbalances associated with PCOS.

Keyphrases

polycystic ovary syndrome
insulin resistance
pregnancy outcomes
cervical cancer screening
metabolic syndrome
pregnant women